Pomalidomide Efficacious in Hereditary Hemorrhagic Telangiectasia

MONDAY, Sept. 23, 2024-- For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis severity, according to a study published in the Sept. 19 issue of the New England Journal of...